Welcome to Trendlines
We invest in, incubate, and support early-stage, high-promise medical and agricultural technology companies in Israel, a global leader in start-up ingenuity. Read More >
Subscribe to Our Newsletter
Stay in Touch
By Stanley Lim Peir Shenq, CFA, The Motley Fool (21 December 2016)
When a foreign company decides to list here in Singapore, some of you may go, “Why?”
In any case, whenever I get to meet management teams from companies that are based outside of the country of their listing, one question I like to ask is: “Why did you choose to list in this country?”
I recently got the chance to ask this question to the co-Chairman and co-CEO of Trendlines Group Ltd (SGX: 42T), [S]teve Rhodes.
Trendlines is a relatively new listed company in Singapore’s stock market, having floated its shares only in November 2015. The company is a venture capital investor based in Israel and it invests mainly in companies that deal with medical devices and agriculture technologies. It is also only the second Israel-based company to be listed in Singapore.
According to Steve, Trendlines had explored a listing in other markets prior to doing so in Singapore.
However, Trendlines understood that it was still a rather small company and it would not be easily recognizable if it was listed in large exchanges such as the Nasdaq, or even the Hong Kong Stock Exchange.